Presentation is loading. Please wait.

Presentation is loading. Please wait.

Myeloablative Transplantation using either Cord Blood or Bone Marrow leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in.

Similar presentations


Presentation on theme: "Myeloablative Transplantation using either Cord Blood or Bone Marrow leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in."— Presentation transcript:

1 Myeloablative Transplantation using either Cord Blood or Bone Marrow leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in Chronic Granulomatous Disease  Priti Tewari, Paul L. Martin, Adam Mendizabal, Suhag H. Parikh, Kristin M. Page, Timothy A. Driscoll, Harry L. Malech, Joanne Kurtzberg, Vinod K. Prasad  Biology of Blood and Marrow Transplantation  Volume 18, Issue 9, Pages (September 2012) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure 1 Cumulative incidence of neutrophil engraftment to 0.5 × 109/L after the first transplantation. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Figure 2 (A) Cumulative incidence of grades II to IV and III to IV acute graft-versus-host disease (GVHD). (B) Cumulative incidence of overall chronic GVHD (cGVHD) and of extensive chronic GVHD. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Myeloablative Transplantation using either Cord Blood or Bone Marrow leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in."

Similar presentations


Ads by Google